Related Experiment Videos
Neodymium: YAG transscleral cyclocoagulation: a clinical study
1Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berks.
Eye (London, England)
|January 1, 1990
Summary
Neodymium: YAG (Nd:YAG) laser cyclocoagulation effectively lowered intraocular pressure (IOP) in complex glaucoma cases. This safe treatment improved glaucoma control for most patients after surgery failed.
Area of Science:
- Ophthalmology
- Medical Technology
- Laser Surgery
Background:
- Glaucoma is a leading cause of irreversible blindness.
- Uncontrolled glaucoma necessitates advanced treatment strategies.
- Previous glaucoma surgeries can fail, leading to complex cases.
Purpose of the Study:
- To evaluate the efficacy and safety of Neodymium: YAG (Nd:YAG) laser cyclocoagulation.
- To assess IOP reduction in patients with failed glaucoma surgery.
- To determine the effectiveness of Nd:YAG laser in complex glaucoma management.
Main Methods:
- Transscleral cyclocoagulation using a Neodymium: YAG (Nd:YAG) laser in free running mode.
- Treatment applied to 37 eyes of 35 patients with uncontrolled glaucoma.
- Data collected on pre- and post-operative intraocular pressure (IOP).
Main Results:
- Mean pre-treatment IOP was 41 mmHg; mean post-operative IOP was 22.5 mmHg.
- 73% of eyes (27/37) achieved an IOP of 25 mmHg or less.
- Average follow-up duration was eight months.
Conclusions:
- Nd:YAG laser cyclocoagulation is a safe and effective treatment for complex glaucoma.
- This method significantly lowers IOP and improves glaucoma control.
- It offers a viable option for patients with previously failed glaucoma surgeries.